Cargando…
The Oxford study of Calcium channel Antagonism, Cognition, Mood instability and Sleep (OxCaMS): study protocol for a randomised controlled, experimental medicine study
BACKGROUND: The discovery that voltage-gated calcium channel genes such as CACNA1C are part of the aetiology of psychiatric disorders has rekindled interest in the therapeutic potential of L-type calcium channel (LTCC) antagonists. These drugs, licensed to treat hypertension and angina, have previou...
Autores principales: | Atkinson, Lauren Z., Colbourne, Lucy, Smith, Alexander, Harmer, Catherine H., Nobre, Anna C., Rendell, Jennifer, Jones, Helen, Hinds, Christopher, Mould, Arne, Tunbridge, Elizabeth M., Cipriani, Andrea, Geddes, John R., Saunders, Kate E. A., Harrison, Paul J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373140/ https://www.ncbi.nlm.nih.gov/pubmed/30755265 http://dx.doi.org/10.1186/s13063-019-3175-0 |
Ejemplares similares
-
Oxford Lithium Trial (OxLith) of the early affective, cognitive, neural and biochemical effects of lithium carbonate in bipolar disorder: study protocol for a randomised controlled trial
por: Saunders, Kate E. A., et al.
Publicado: (2016) -
Biochemical and genetic predictors and correlates of response to lamotrigine and folic acid in bipolar depression: Analysis of the CEQUEL clinical trial
por: Tunbridge, EM, et al.
Publicado: (2017) -
The Oxford Renal (OxRen) cross-sectional study of chronic kidney disease in the UK
por: Hill, Nathan R, et al.
Publicado: (2013) -
The Chinese Version of Oxford Depression Questionnaire: A Validation Study in Patients with Mood Disorders
por: Zhu, Yiyi, et al.
Publicado: (2023) -
Innovative approaches to bipolar disorder and its treatment
por: Harrison, Paul J., et al.
Publicado: (2016)